Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Therapy for Fatigue in Prostate Cancer
NCT01410942Phase 2Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2012
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate hydrochloride extended-release chewable tablet in fatigue, sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2012; status: active, not recruiting.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT01410942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01410942.